Trace Of Pollen Determines Source Of Counterfeit Anti-malaria Drug In China
This article was originally published in PharmAsia News
Executive Summary
An investigation of counterfeit drugs in China exported to other countries disclosed a new method of determining the source of illegitimate ingredients. Guilin Pharmaceutical's anti-malaria drug based on the sweet wormwood plant was the target of counterfeiters. Investigators were able to trace particles of a type of pollen and calcite to a particular region of China. The counterfeits of the artesunate-based drug are of concern because they could lead to an artesunate-resistant form of malaria. (Click here for more